The Chinese government took its economic sanctions against San Diego-based Illumina a step further Tuesday by banning the ...

Illumina Inc (NASDAQ:ILMN)., a leading player in the genomic sequencing industry ... volume growth or cost reductions. What risks does Illumina face in the China market? Illumina's challenges ...

Beijing banned imports of Illumina’s gene-sequencing machines in response to U.S. tariffs.

The San Diego company also lowered its financial guidance for 2025 in response to China’s import restrictions.

Illumina has been barred from exporting its DNA sequencers to China, which closed | Illumina has been barred from exporting ...

China banned the import of Illumina Inc. gene-sequencing machines as part of a wave of retaliatory measures against fresh US ...

Illumina is not banned from operating in the country and will continue to serve its existing customers, a company ...

Illumina aims to transform human health practices through its leadership of genomic sequencing and related ... mid-2024 directly to shareholders. We do not think the current market value of ...

China banned the import of Illumina Inc. gene-sequencing machines as part of a wave of retaliatory measures against fresh US tariffs on all Chinese goods, deepening the US company’s woes in one ...

Illumina Inc (NASDAQ:ILMN)., a leading player in the genomic sequencing industry ... price decreases with sufficient volume growth or cost reductions. What risks does Illumina face in the China market ...